Primary growth hormone insensitivity and psychomotor delay

Area of Science:

• Pediatric Endocrinology
• Genetics
• Growth Disorders

Background:

• Growth hormone (GH) deficiency is a common cause of short stature.
• Provocative testing and insulin-like growth factor 1 (IGF-1) levels are standard diagnostic tools.
• GH replacement therapy is the established treatment for GH deficiency.

Observation:

• A case of short stature presented with low GH response and undetectable IGF-1 levels, initially suggesting GH deficiency.
• The patient showed a paradoxical response to GH replacement therapy, indicating GH insensitivity.

Findings:

• The patient's clinical presentation and therapeutic response pointed towards GH insensitivity despite initial diagnostic indicators of deficiency.
• This highlights the complexity in diagnosing GH-related growth disorders.

Implications:

• Molecular evaluation of the GH/IGF-1 axis is essential for differentiating GH deficiency from GH insensitivity.
• Accurate diagnosis is critical for tailoring effective therapeutic interventions.
• Understanding GH insensitivity mechanisms can lead to novel treatment approaches for short stature.